Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00716066
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:21.039383+00:00
Published At
2026-02-27T00:00:00+00:00
Record Updated At
2026-02-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Autoimmune Disease", "Neurologic Autoimmune Disease", "Autologous Transplant Autoimmune", "Multiple Sclerosis Transplant", "MS Stem Cell Transplant", "Multiple Sclerosis Stem Cell Transplant", "Stiff Person Syndrome", "HCT for Neurologic Autoimmune Disorders", "CIDP Transplant", "Myasthenia Gravis Transplant", "Autoimmune Nervous System Disorder", "Central Nervous System Vasculitis", "Cerebellar Degeneration", "Chronic Inflammatory Demyelinating Polyneuropathy", "Lambert Eaton Myasthenic Syndrome", "Myasthenia Gravis", "Neuromyelitis Optica", "Opsoclonus Myoclonus Syndrome", "Rasmussen Subacute Encephalitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-27"
protocolSection.identificationModule.nctId
"NCT00716066"
protocolSection.identificationModule.officialTitle
"High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Autoimmune Disease (protocolSection.conditionsModule.conditions)
  • Neurologic Autoimmune Disease (protocolSection.conditionsModule.conditions)
  • Autologous Transplant Autoimmune (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis Transplant (protocolSection.conditionsModule.conditions)
  • MS Stem Cell Transplant (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis Stem Cell Transplant (protocolSection.conditionsModule.conditions)
  • Stiff Person Syndrome (protocolSection.conditionsModule.conditions)
  • HCT for Neurologic Autoimmune Disorders (protocolSection.conditionsModule.conditions)
  • CIDP Transplant (protocolSection.conditionsModule.conditions)
  • Myasthenia Gravis Transplant (protocolSection.conditionsModule.conditions)
  • Autoimmune Nervous System Disorder (protocolSection.conditionsModule.conditions)
  • Central Nervous System Vasculitis (protocolSection.conditionsModule.conditions)
  • Cerebellar Degeneration (protocolSection.conditionsModule.conditions)
  • Chronic Inflammatory Demyelinating Polyneuropathy (protocolSection.conditionsModule.conditions)
  • Lambert Eaton Myasthenic Syndrome (protocolSection.conditionsModule.conditions)
  • Myasthenia Gravis (protocolSection.conditionsModule.conditions)
  • Neuromyelitis Optica (protocolSection.conditionsModule.conditions)
  • Opsoclonus Myoclonus Syndrome (protocolSection.conditionsModule.conditions)
  • Rasmussen Subacute Encephalitis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.